Investment
Features
FeesSafety
Academy
More
Pluang+

Compare McKesson Corporation (MCK) vs M&T Bank Corporation (MTB) Price & Performance

McKesson CorporationTrade
M&T Bank CorporationTrade

Price performance (Past 24H)

Key statistics

McKesson Corporation vs M&T Bank Corporation — how do they compare? McKesson Corporation trades at $940.73 (market cap $108.46B), while M&T Bank Corporation trades at $217.75 (market cap $31.42B). The key difference: McKesson Corporation is far larger — about 3.5× M&T Bank Corporation's market cap, and M&T Bank Corporation pays the higher dividend (2.76%). Which is the better fit depends on your goals — on Pluang, investors hold McKesson Corporation for 74 Days and M&T Bank Corporation for 100 Days on average.

MCKMTB
Market Cap
$108.46B$31.42B
Volume
712,6071,438,219
Sector
HealthFinancials
52-Week High
$995.69$254.09
52-Week Low
$725.17$178.63
Typical Hold Time
74 Days100 Days
Enterprise Value
$115.00B$47.77B
Dividend Yield
0.4%2.76%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

McKesson Corporation

McKesson Corporation (MCK) trades at $937.98, up 3.04% with strong technical momentum and bullish analyst sentiment. The stock shows consistent earnings beats with Q2 2026 EPS of $9.93 exceeding expectations of $9.56. Recent positive developments include the CVS Health partnership extension through 2032 and raised full-year guidance. Revenue growth remains robust at $359.05 billion for 2025, though net margins are thin at 1.12%.

The outlook remains positive with 81% analyst buy ratings and a $956.43 consensus target. Key risks include margin pressure from drug pricing dynamics and policy uncertainty. Strong cash flow generation ($6.09B operating cash flow) supports the dividend and growth initiatives, while technical indicators show the stock testing resistance near $938.

M&T Bank Corporation

M&T Bank Corporation (MTB) trades at $217.23, up 0.29% with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with P/E of 11.52, net margin of 30.85%, and consistent dividend payments. Recent news highlights branch expansion and AI investments driving loan growth, while analyst consensus remains cautiously optimistic with a $258.92 price target.

MTB presents a compelling value opportunity with attractive valuation metrics and solid profitability, though technical indicators suggest near-term pressure. The bank's strategic investments in technology and expanding fee businesses support long-term growth, but investors should monitor interest rate sensitivity and competitive banking sector dynamics.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MCK
100% Buy0% Sell
Avg holding period · 74 Days
MTB

No sentiment data available yet.

Top news

Latest headlines on both assets

About McKesson Corporation

McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

Read more on MCK →

About M&T Bank Corporation

M&T Bank is one of the largest regional banks in the United States, with branches in New York, Pennsylvania, West Virginia, Virginia, Maryland, Delaware, and New Jersey. The bank was founded to serve manufacturing and trading businesses around the Erie Canal and is primarily focused on commercial real estate and commercial-related lending, with some retail operations also present.

Read more on MTB →